STDN vs IOSP
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
STDN · Standard Nuclear$8.14 ▼ 9.66%
IOSP · Innospec$75.56 ▼ 1.97%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- STDN -22.6%
- IOSP -7.7%
Head to head
| Metric | STDN | IOSP |
|---|---|---|
| Price | $8.14 | $75.56 |
| Change today | ▼ 9.66% | ▼ 1.97% |
| Market cap | $1.28B | $1.86B |
| Return, 3 months | -31.8% | -18.7% |
| Return, year to date | – | -0.1% |
| Return, 1 year | – | +7.9% |
| P/E (TTM) | – | 13.3 |
| P/B | 4.7 | 1.4 |
| P/E percentile vs own 5y | 94th | 6th |
| Dividend yield | – | 2.37% |
| Revenue growth (YoY, latest qtr) | +756.5% | +7.2% |
| Net profit growth (YoY) | -109.9% | +148.8% |
| Gross margin | -57.7% | 27.7% |
| Operating margin | -245.7% | 8.5% |
| Net margin | -222.3% | 7.5% |
| Return on equity | – | 10.5% |
| Analyst target vs. price | +110.9% | +45.6% |
| Analyst buy share | 100% | 100% |
| RSI (14) | 26 | 30 |
| 30-day volatility | 76.9% | 63.4% |
| Max drawdown, 1 year | -50.8% | -25.5% |
| Trend read | Strong downtrend | Strong downtrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- IOSP is the largest of the group by market value.
- STDN is growing revenue fastest.
- IOSP keeps the most profit per dollar of sales.
- IOSP has been the calmest stock over the last 30 days.